| CSF AD biomarker sample | CSF vascular biomarker sample | ||
---|---|---|---|---|
Female (n = 178) | Male (n = 153) | Female (n = 141) | Male (n = 108) | |
Age (years) | 57.5 (16.8) (21–100) | 56.0 (19.6) (22–88) | 70.0 (8.5) (50–100) | 72.1 (9.1) (50–90) |
BMI (kg/m2) | 25.8 (4.3) (18–41) | 26.4 (3.4) (20–37) | 25.7 (4.3) (18–39) | 26.3 (3.0) (20–36) |
Education (years) | 15.8 (2.5) (10–22) | 16.5 (2.8)* (10–27) | 15.8 (2.5) (9–23) | 16.2 (2.6) (10–25) |
MMSE score | 29.3 (0.9) (26–30) | 29.2 (1.2) (25–30) | 29.5 (0.9) (25–30) | 28.8 (1.4)* (24–30) |
APOE-ε4 positive, n (%) | 67 (38) | 48 (31) | 49/136 (36) | 33/100 (33) |
Aβ42 (pg/ml) | 331 (135) (63–821) | 323 (116) (98–801) |  |  |
Total tau (pg/ml) | 47.9 (13.4) (7–91) | 50.5 (15.0) (18–130) |  |  |
p-tau181 (pg/ml) | 31.3 (8.4) (<7–67) | 32.6 (12.7) (9–107) |  |  |
E-selectin (pg/ml) |  |  | 42.1 (33.2) (1.5–188) | 60.3 (42.1) (1.5–226) |
VCAM1 (ng/ml) |  |  | 115 (59) (34–343) | 147 (70) (42–429) |